Aluminum exposure through parenteral nutrition formulations: Mathematical versus clinical relevance

2005 ◽  
Vol 62 (3) ◽  
pp. 315-318 ◽  
Author(s):  
Todd W. Canada
2011 ◽  
Vol 16 (2) ◽  
pp. 92-97
Author(s):  
Robert L. Poole ◽  
Kevin P. Pieroni ◽  
Shabnam Gaskari ◽  
Tessa K. Dixon ◽  
KT Park ◽  
...  

ABSTRACT OBJECTIVE Aluminum is a contaminant in all parenteral nutrition solutions. Manufacturers currently label these products with the maximum aluminum content at the time of expiry, but there are no published data to establish the actual measured concentration of aluminum in parenteral nutrition solution products prior to being compounded in the clinical setting. This investigation assessed quantitative aluminum content of products commonly used in the formulation of parenteral nutrition solutions. The objective of this study is to determine the best products to be used when compounding parenteral nutrition solutions (i.e., those with the least amount of aluminum contamination). METHODS All products available in the United States from all manufacturers used in the production of parenteral nutrition solutions were identified and collected. Three lots were collected for each identified product. Samples were quantitatively analyzed by Mayo Laboratories. These measured concentrations were then compared to the manufacturers' labeled concentration. RESULTS Large lot-to-lot and manufacturer-to-manufacturer differences were noted for all products. Measured aluminum concentrations were less than manufacturer-labeled values for all products. CONCLUSIONS The actual aluminum concentrations of all the parenteral nutrition solutions were significantly less than the aluminum content based on manufacturers' labels. These findings indicate that 1) the manufacturers should label their products with actual aluminum content at the time of product release rather than at the time of expiry, 2) that there are manufacturers whose products provide significantly less aluminum contamination than others, and 3) pharmacists can select products with the lowest amounts of aluminum contamination and reduce the aluminum exposure in their patients.


Nutrients ◽  
2012 ◽  
Vol 4 (11) ◽  
pp. 1566-1574 ◽  
Author(s):  
Robert Poole ◽  
Kevin Pieroni ◽  
Shabnam Gaskari ◽  
Tessa Dixon ◽  
John Kerner

1967 ◽  
Vol 18 (03/04) ◽  
pp. 664-669 ◽  
Author(s):  
S Cronberg ◽  
Inga Marie Nilsson

SummaryA single infusion of a fat emulsion, Intralipid®, used for parenteral nutrition was given to 11 healthy normals, 3 patients with von Willebrand’s disease and 3 with mild or moderately severe thrombasthenia. The infusion had no effect on coagulation or the fibrinolytic system. Platelet adhesiveness, as determined with Hellem’s whole blood method, was markedly increased but not with his plasma-ADP method or with Salzman’s method. No shortening of the bleeding time was observed in the normals or in the patients with prolonged bleeding time. The change observed in platelet adhesiveness is therefore believed to be an in vitro artefact with no clinical relevance.


2008 ◽  
Vol 42 (10) ◽  
pp. 1410-1415 ◽  
Author(s):  
Rex O Brown ◽  
Laurie M Morgan ◽  
Syamal K Bhattacharya ◽  
Patti L Johnson ◽  
Gayle Minard ◽  
...  

Background: Patients' exposure to and potential toxicity from aluminum in parenteral nutrition (PN) formulations is an important concern of healthcare providers. Objective: To determine the potential for aluminum toxicity caused by PN in hospitalized adults who have risk factors of both acute kidney injury and PN. Methods: Adults who required PN and had a serum creatinine (SCr) level at least 1.5 times greater than the admission SCr on the first day of PN were studied in a retrospective fashion. Protein was administered based on whether hemodialysis was being used (0 6-1 g/kg/day without hemodialysis; 1.2-1.5 g/kg/day with hemodialysis). Aluminum exposure was determined for each patient by multiplying the volume of each PN component by its concentration of aluminum Unpaired f-tests, Fisher's exact test, and analysis of variance were used for statistical analysis. Data are presented as mean ± SD. Results: Thirty-six patients (aged 50.4 ± 20.4 y; weight 90.2 ± 32.8 kg) were studied. Initial serum urea nitrogen and SCr were 47 ± 23 and 3.3 ± 1.4 mg/dL. respectively. Twelve patients received hemodialysis. The mean aluminum exposure was 3.8 ± 2 μg/kg/day in the 36 patients, Of these, 29 had safe calculated aluminum exposure (<5 μg/kg/day) and 7 had high calculated aluminum exposure (>5 μg/kg/day), Patients with safe aluminum exposure had significantly higher SCr levels than did those with high aluminum exposure (3.5 ± 1.5 vs 2.2 ± 0.7 mg/dL; p < 0.04). Patients with high aluminum exposure received significantly more aluminum from calcium gluconate compared with those who had safe aluminum exposure (357 ± 182 vs 250 ± 56 μg/day; p < 0.02). Limitations of the study include its retrospective design, which resulted in calculated versus direct measurement of aluminum. Conclusions: Using our calculations, we believe that most patients with acute kidney injury who require PN do not receive excessive exposure to aluminum from the PN formulation, despite having 2 risk factors (acute kidney injury, PN) for aluminum toxicity,


Nutrients ◽  
2017 ◽  
Vol 9 (11) ◽  
pp. 1249 ◽  
Author(s):  
Megan Fortenberry ◽  
Lela Hernandez ◽  
Jacob Morton

2008 ◽  
Vol 32 (3) ◽  
pp. 242-246 ◽  
Author(s):  
Robert L. Poole ◽  
Susan R. Hintz ◽  
Nicol I. Mackenzie ◽  
John A. Kerner

PEDIATRICS ◽  
1990 ◽  
Vol 86 (4) ◽  
pp. 650-651
Author(s):  
Philippe Goyens ◽  
Daniel Brasseur

To the Editor.— Litov and co-workers1 address an important question regarding aluminum loading in infants. Aluminum is a toxic element. Its retention results in an increase in the body burden of aluminum. This has been shown to be a health hazard in patients with compromised kidney function and in those receiving total parenteral nutrition. The aluminum content of soy-based infant formulas is known to be high.2 The authors report their finding of normal plasma aluminum levels in infants fed a soybased formula during the first 3 months of life, and they suggest that the ingestion of "amounts of aluminum severalfold greater than that found in human milk" is of no clinical relevance.


2008 ◽  
Vol 27 (6) ◽  
pp. 858-864 ◽  
Author(s):  
Patrizia Nardo ◽  
Yves M. Dupertuis ◽  
Josiane Jetzer ◽  
Michel P. Kossovsky ◽  
Patrice Darmon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document